NVCR

Novocure Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth 3/10
  • Momentum 2/10
Novocure sales and earnings growth
NVCR Growth
Neutral
  • Revenue Y/Y 11.17%
  • EPS Y/Y -15.83%
  • FCF Y/Y 16.67%
Novocure gross and profit margin trends
NVCR Profitability
Neutral
  • Gross margin 75.40%
  • EPS margin -27.70%
  • ROIC -17.00%
Novocure net debt vs free cash flow
NVCR Risk
Fair
  • Debt / Equity 2.3
  • Debt / FCF 7.0
  • Interest coverage -6.7

Novocure stock volatility is in-line with the overall market. We give it a Fair risk rating.

More Medical Devices stocks ↗